Ceramide AD™ Restores Skin Integrity and Function following Exposure to House Dust Mite

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?

Comparative study of normal and sensitive skin aerobic bacterial populations

Effects of long-term strontium ranelate treatment on vertebral fracture risk in postmenopausal women with osteoporosis

Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture

Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries

[Phototype, vitamin D status and bone mineral density among women at risk of osteoporosis]

Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors

Evaluation and development of automatic two-dimensional measurements of histomorphometric parameters reflecting trabecular bone connectivity: correlations with dual-energy x-ray absorptiometry and quantitative ultrasound in human calcaneum

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study

Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women

Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study

[Strontium ranelate: new therapeutic agent for postmenopausal osteoporosis]

Estimated number of women likely to benefit from bone mineral density measurement in France

[New methods to measure bone quality]

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis

[Comparison of early bone histomorphometric effects of parathormone and alendronate in osteoporotic women]

Does follow-up duration influence the ultrasound and DXA prediction of hip fracture? The EPIDOS prospective study

Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies

[Large clinical trials for osteoporosis]

Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women

The mineralization of bone tissue: a forgotten dimension in osteoporosis research

Design and methodology of the phase 3 trials for the clinical development of strontium ranelate in the treatment of women with postmenopausal osteoporosis

Effects of bisphosphonates on matrix mineralization

Intravenous zoledronic acid in postmenopausal women with low bone mineral density

Is vitamin K deficiency a risk factor for osteoporosis in Crohn's disease?

Histomorphometric approach of bone loss in men

Anabolic agents for treating postmenopausal osteoporosis

Alendronate and estrogen effects in postmenopausal women with low bone mineral density. Alendronate/Estrogen Study Group

Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines

Bone histomorphometry of transiliac paired bone biopsies after 6 or 12 months of treatment with oral strontium ranelate in 387 osteoporotic women: randomized comparison to alendronate

Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial

Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis--a 2-year randomized placebo controlled trial

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group

Bone histomorphometry in untreated and treated glucocorticoid-induced osteoporosis

Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis

Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies

Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study

Prevalence of Paget's disease of bone and spinal hemangioma in French women older than 75 years: data from the EPIDOS study

Which screening strategy using BMD measurements would be most cost effective for hip fracture prevention in elderly women? A decision analysis based on a Markov model

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group

Strontium ranelate prevents quality of life impairment in post-menopausal women with established vertebral osteoporosis

Cross-cultural validation and analysis of responsiveness of the QUALIOST: QUAlity of Life questionnaire In OSTeoporosis

Which screening strategy using BMD measurements would be most cost effective for hip fracture prevention in elderly women? A decision analysis based on a Markov model

Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters

Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis

The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report

Addressing the musculoskeletal components of fracture risk with calcium and vitamin D: a review of the evidence